CONGENITAL ADRENAL HYPERPLASIA
Clinical trials for CONGENITAL ADRENAL HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL ADRENAL HYPERPLASIA trials appear
Sign up with your email to follow new studies for CONGENITAL ADRENAL HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with rare hormone disorder: drug may cut steroid doses
Disease control TerminatedThis study tested a drug called tildacerfont in 67 children aged 2 to 17 with congenital adrenal hyperplasia (CAH), a condition where the body can't make certain hormones properly. The goal was to see if the drug is safe and can help control the disease while reducing the need fo…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Hope for CAH patients: can tildacerfont cut steroid needs?
Disease control TerminatedThis study tested a drug called Tildacerfont in 100 adults with classic congenital adrenal hyperplasia (CAH), a condition where the body can't make certain hormones properly. The goal was to see if it could safely reduce the high doses of steroids patients need to take. The study…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Early-Stage drug trial for rare hormone disorder in kids ends early
Disease control TerminatedThis study tested a drug called abiraterone acetate in 4 children with congenital adrenal hyperplasia (CAH), a condition that causes hormone imbalances and early growth problems. The goal was to see if it could lower the dose of hydrocortisone needed to control the disease. The s…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated May 18, 2026 12:12 UTC